Document Detail


Promoting health after gestational diabetes: a national diabetes education program call to action.
MedLine Citation:
PMID:  22183225     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The National Diabetes Education Program joins the American College of Obstetricians and Gynecologists (the College) to promote opportunities for obstetrician-gynecologists (ob-gyns) and other primary care providers to better meet the long-term health needs of women with prior gestational diabetes mellitus (GDM) and their children. Up to one third of GDM women may have diabetes or prediabetes postpartum, yet only about half of these women are tested postpartum, and about a quarter are tested 6-12 weeks postpartum. Women with GDM face a lifelong increased risk for subsequent diabetes, primarily type 2 diabetes mellitus. Timely testing for prediabetes may provide an opportunity for ob-gyns to prevent or delay the onset of type 2 diabetes mellitus through diet, physical activity, weight management, and pharmacologic intervention. The College and the American Diabetes Association recommend testing women with a history of GDM at 6-12 weeks postpartum. If the postpartum test is normal, retest every 3 years and at the first prenatal visit in a subsequent pregnancy. If prediabetes is diagnosed, test annually. Because children of GDM pregnancies face an increased risk for obesity and type 2 diabetes mellitus, families need support to develop healthy eating and physical activity behaviors. Current criteria indicate that GDM occurs in 2% to 10% of all pregnancies. If new GDM diagnostic criteria are used, the frequency of GDM may increase to about 18% of pregnancies annually. The projected increase in the number of women with GDM and the potential subsequent associated risks underscore the need for proactive long-term primary care treatment of the mother and her children.
Authors:
Steven G Gabbe; Mark B Landon; Elizabeth Warren-Boulton; Judith Fradkin
Related Documents :
11606455 - Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induce...
19587355 - Selective inhibition of protein kinase c beta(2) attenuates inducible nitric oxide synt...
4069805 - An experimental model for studies of fetal maldevelopment in the diabetic pregnancy.
10459535 - Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabet...
489615 - Insulin-induced insulin resistance of alpha-aminoisobutyric acid transport in cultured ...
14759285 - The potential risks of abnormal transmission of mtdna through assisted reproductive tec...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  119     ISSN:  1873-233X     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  171-6     Citation Subset:  AIM; IM    
Affiliation:
From Health Sciences and the Department of Obstetrics and Gynecology, The Ohio State University Medical Center, Columbus, Ohio; Hager Sharp, Inc., Washington, DC; and the Division of Diabetes, Endocrinology and Metabolic Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  What is new in maternal-fetal medicine?: best articles from the past year.
Next Document:  Work … life … balance?